| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/14/2006 | CN1259331C Nucleoside analogue lipid derivative and salt thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259105C Buccal tablet of recombined human interferon alpha 2b and producing method |
| 06/14/2006 | CN1259102C Pure Chinese medicine tablet for treating liver cirrhosis and complication and preparing process thereof |
| 06/14/2006 | CN1259099C Prepared traditional Chinese drug Liangfu drop pills for treating epigastric pain and preparing process thereof |
| 06/14/2006 | CN1259094C Chinese medicine for treating otitis media and its preparation |
| 06/14/2006 | CN1259093C Medicine for preventing and treating nipple chap and its preparing method |
| 06/14/2006 | CN1259091C External paste for treating burn |
| 06/14/2006 | CN1259089C Chinese medicine for treating cholecystitis and preparing process thereof |
| 06/14/2006 | CN1259083C Hyperostereogeny treating medicine |
| 06/14/2006 | CN1259081C Oral liquid for treating ophthalmic diseases |
| 06/14/2006 | CN1259080C Bacteria and virus resisting and inflammation eliminating eye drop and its preparing process |
| 06/14/2006 | CN1259079C Osteopathy treating ointment |
| 06/14/2006 | CN1259078C Chinese medicine for treating women's chronic pelvic infection and preparing process thereof |
| 06/14/2006 | CN1259070C Health capsule with auxiliary protective function for chemical liver damage and its preparing method |
| 06/14/2006 | CN1259067C Supplementing qi pulse restoring Chinese medicinal preparation and its preparation method |
| 06/14/2006 | CN1259065C Chinese medicinal preparation for quick bone fracture setting |
| 06/14/2006 | CN1259063C Method for preparing non-specific immunity activator |
| 06/14/2006 | CN1259062C External use medicine for treating facial paralysis peripherica and its prepn |
| 06/14/2006 | CN1259060C Chinese forest frog oil powder preparation method |
| 06/14/2006 | CN1259055C Method for preparing azithromycin superfine powder by ultrasound emulsion dissolvent diffusion method |
| 06/14/2006 | CN1259053C Medicinal preparation containing erythromycine ethylsuccinate |
| 06/14/2006 | CN1259050C Oral formulation of hydroxycamptothecin and its preparation method |
| 06/14/2006 | CN1259047C Kudzu vine flavone capsule, and its prepn. method |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/14/2006 | CN1259042C Calcium phenol sulfonate dispersive tablets and their preparation |
| 06/14/2006 | CN1259041C Bromhexine Hydrochloride aseptic freeze-drying formulation for injection and its preparation method |
| 06/14/2006 | CN1259040C Albuterol time controlling pulse slow release oral preparation and its preparation method |
| 06/14/2006 | CN1259039C Huoxiang Zhengqi liquid capsule and its preparation |
| 06/14/2006 | CN1259038C Radix bupleuri soft capsule pharmaceutics and preparation process thereof |
| 06/14/2006 | CN1259037C Orally disintegrating tablet of antiviral medicine and its preparation process |
| 06/14/2006 | CN1259036C Breviscapine drop pills and preparing method |
| 06/14/2006 | CN1259035C Chinese medicinal preparation of anti embolus disease and its preparation method |
| 06/14/2006 | CN1259003C Method for molecular press dehydration of vegetative tissue, dehydrated tissues and dehydrated exudates obtained and processing products containing same |
| 06/13/2006 | US7060828 Angiogenosis inhibitor; anticancer agents |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060732 Antiacne; skin disorders; packaged separately |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060708 Active agent delivery systems and methods for protecting and administering active agents |
| 06/13/2006 | US7060694 High potency dihydroergotamine compositions |
| 06/13/2006 | US7060691 Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060672 Cyclosporin analog formulations |
| 06/13/2006 | US7060307 Topical composition for heightened sensitivity |
| 06/13/2006 | US7060305 extracts contain higher concentration of isoflavones; used to treat erectile dysfunction or malfunction |
| 06/13/2006 | US7060302 Metal-containing compositions, preparations and uses |
| 06/13/2006 | US7060299 Biodegradable microparticles that stabilize and control the release of proteins |
| 06/13/2006 | US7060298 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/13/2006 | US7060297 Transitional viscoelastics (having non-shear related variable viscosities) contain kappa-carrageenans, potassium and second sulfated polysachharide for protecting or stabilizing eye tissues during surgery |
| 06/13/2006 | US7060296 Biodegradation, time-release agents, drug delivery |
| 06/13/2006 | US7060295 Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus |
| 06/13/2006 | US7060294 A compressed tablet made of efavirenz, filler/ disintegrant, superdisintegrant, binder, surfactant, diluent/compression aid, lubricant, and solvent; useful for treating HIV infections and AIDS |
| 06/13/2006 | US7060293 high-load immediate release multiparticulate formulation of morphine for oral administration; powder-layered spheroids bioavailable which avoid the necessity for organic solvents; minimizes the food effect |
| 06/13/2006 | US7060292 Lipid structures and uses thereof |
| 06/13/2006 | US7060291 includes a fusogenic liposome (a lipid bilayer encapsulating contents), a linking moiety (electrostatically bound to the lipid bilayer) and a targeting moiety (covalently bound to the linking moiety); |
| 06/13/2006 | US7060290 Phosphocholine linked prodrug derivatives |
| 06/13/2006 | US7060289 Topical glycopyrrolate product |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060263 Super absorption Coenzyme Q10 |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | US7060255 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/13/2006 | US7060059 System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device |
| 06/13/2006 | US7059857 Substantially solid desensitizing compositions and devices having a tray-like configuration and methods of manufacturing and using such compositions and devices |
| 06/13/2006 | US7059348 Drug delivery system |
| 06/13/2006 | CA2366623C Resorcinol composition |
| 06/13/2006 | CA2309836C Drug delivery systems utilizing liquid crystal structures |
| 06/13/2006 | CA2302601C Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/13/2006 | CA2188046C Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals |
| 06/08/2006 | WO2006060817A1 Pharmaceutical compositions |
| 06/08/2006 | WO2006060759A2 A sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal |
| 06/08/2006 | WO2006060723A2 Methods for producing block copolymer/amphiphilic particles |
| 06/08/2006 | WO2006060711A2 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
| 06/08/2006 | WO2006060698A1 Nanoparticulate benzothiophene formulations |
| 06/08/2006 | WO2006060681A2 Pharmaceutical composition containing an anti-nucleating agent |
| 06/08/2006 | WO2006060618A2 Topical nepafenac formulations |
| 06/08/2006 | WO2006060515A2 System for improved percutaneous absorption of skin benefiting agents |
| 06/08/2006 | WO2006060464A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers |
| 06/08/2006 | WO2006060325A2 Coated drug delivery formulations |
| 06/08/2006 | WO2006060120A2 Liposomal formulation for oral administration of glutathione (reduced) |
| 06/08/2006 | WO2006059939A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| 06/08/2006 | WO2006059866A1 Sustained release formulation containing selective serotonin reuptake inhibitor and method for the preparation thereof |
| 06/08/2006 | WO2006059846A1 Formulation of sec1 mutated protein and method for formulation of the same |
| 06/08/2006 | WO2006059716A1 Solid preparation |
| 06/08/2006 | WO2006059344A1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 06/08/2006 | WO2006059224A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
| 06/08/2006 | WO2006059217A1 Stable solid dosage forms of amlodipine besylate and processes for their preparation |
| 06/08/2006 | WO2006059180A2 Process of preparation of biodegradable films from semi refined kappa carrageenan |
| 06/08/2006 | WO2006059152A2 Pharmaceutical formulations |
| 06/08/2006 | WO2006059141A2 Protein delivery system |
| 06/08/2006 | WO2006059078A1 Cosmetic patch for skin treatment |
| 06/08/2006 | WO2006058671A1 Aqueous dispersions of a mixture of only slightly water soluble or water insoluble active substances and a single-celled protein material |
| 06/08/2006 | WO2006058536A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 06/08/2006 | WO2006044805A3 Less abusable pharmaceutical preparations |
| 06/08/2006 | WO2006042336A3 Removal of impurities with supercritical fluids from ocular drug delivery devices during manufacturing |
| 06/08/2006 | WO2006039499A3 Method for improving the biovailability of orally delivered therapeutics |
| 06/08/2006 | WO2006033948A3 Sustained local anesthetic composition containing preferably a sugar ester such as saib |
| 06/08/2006 | WO2006023286A3 Controlled release nanoparticle active agent formulation dosage forms and methods |